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ABSTRACT
Background: Acute mastiffs commonly occurs in the postpartum period. It has been reported only
rarely in the antepartum period.
Case:A 14-year-old patient presented at 29 weeks gestation with her symptoms and examination
consistent with bilateral mastiffs that had worsened over 2 months. She had evidence of systemic
infection. She was treated with parenteral antibiotics and local skin care. She gradually improved
and delivered a healthy infant at term.
Conclusion: The management of antepartum mastiffs can be derived from experience with puer-
peral mastiffs. It must include early recognition, a search for predisposing factors and causative
organisms, and aggressive treatment. Such an approach can lead to successful pregnancy outcome
with minimal fetal or maternal morbidity. (C) 1995 Wiley-Liss, Inc.
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cute mastitis associated with pregnancy is a
common problem with an estimated incidence
of 1-9%.
1-4 The majority of the cases occur post-
partum, usually within 6 weeks of delivery. 2’3’5
The occurrence of acute mastitis in the antenatal
period is uncommon to rare. Only 3 cases have
been reported in the obstetrical literature in the past
20 years, probably representing underreporting.
1,6
We report a case of chronic sporadic mastitis occur-
ring during gestation that required hospitalization
and IV antibiotics.
CASE REPORT
A 14-year-old primigravida presented for prenatal
care at 29 weeks gestation, complaining of bilateral
breast pruritus for 2 months. She reported that her
breasts had become progressively more red and
sore. She had received no prenatal care or medical
attention for her breast symptoms prior to this visit.
She had no significant medical, surgical, or family
history, and no known allergies. She had come to
the United States from the Philippines month
earlier but denied any known infectious or environ-
mental exposures, illicit drug use, breast trauma,
or manipulation other than scratching. There was
no historical or physical evidence of abuse.
Her temperature was 37.5C (normal). Bilat-
eral excoriations, ulcerations, and erythema were
noted on the surface of the breasts. There were also
bilateral induration involving the areola and breast
tissue (9 7-cm area on the right and 3 2-cm
area on the left), purulent drainage from both nip-
ples, and bilateral axillary adenopathy. The uterine
fundus was nontender and measured 26 crn. The
remainder of the physical exam was within normal
limits.
The initial laboratory studies showed a leukocyte
count of 18,300 with 78% neutrophils and 11%
lymphocytes. The hematocrit was 27% and the he-
moglobin was 8.4 g/dl. The platelet count was
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483,000/lxl. The chemistry and electrolyte panels
were normal. Electronic fetal monitoring revealed
a reactive nonstress test and no uterine contractions.
Ultrasound showed a single, active, intrauterine
pregnancy consistent with 29 weeks gestation. A
diagnosis of chronic antepartum bilateral mastitis
was made. The patient was admitted to the obstetri-
cal service for parenteral antibiotic therapy with
nafcillin (2 g q 4 h), metronidazole (500 mg q 6
h), and aggressive local care with hot soaks and
twice daily wet-to-dry dressing changes.
Subsequently, hepatitis studies, syphilis serol-
ogy, glucose challenge test, and cervical cultures
for gonococcus and chlamydia returned negative. A
culture from the nipple discharge grew Staphylococ-
cus aureus that was resistant to penicillin but sensi-
tive to most other antibiotics including nafcillin.
The patient remained afebrile throughout her hos-
pitalization, and her leukocytosis resolved. Her
breast examinations slowly showed improvement.
On the 7th hospital day, the skin ulcerations were
granulating, the areas of induration were markedly
decreased in size and tenderness, and there was only
scant serous drainage from the right breast. The
patient was discharged on oral dicloxacillin (500
mg q 6h) for 3 weeks and continued local breast
care.
The remainder of the patient’s antepartum course
was unremarkable. She had a spontaneous vaginal
delivery at 41 weeks gestation of a live female
infant weighing 3,440 g with Apgar scores of 8 and
9. At the time of delivery, she still had lesions on
her breasts but they were crusted over without evi-
dence of" active infection (no induration, erythema,
or fluctuance). She elected not to breast-feed.
DISCUSSION
Infectious mastitis occurring in the puerperium is
most often a consequence of milk stasis or cracking
of the areolar skin which allows bacteria to gain
entry and cause mammary adenitis or cellulitis and
potentially abscess formation.
2 Such a consistent
predisposing factor is less clear in the few reported
cases of antepartum mastitis.
1,6 Table lists some
of the possible causes and predisposing factors. It is
important that these be investigated so that the pa-
tient can be educated toward prevention. A thor-
ough history, including social service evaluation,
and physical examination of our patient made sub-
stance abuse, physical abuse, and cultural rituals
TABLE I. Possible causes and predisposing factors
in antepartum mastitis
IV-drug abuse
"Skin popping" via dilated mammary veins
Physical abuse
Rough sexual contact
Cigarette or other burns
Human bites
Cultural rituals
"Toughening" the nipples
Abrasions from "coining"
Application of caustic substances (alcohol, benzoin)
Dermatologic conditions (pruritus)
Fungal infections
Eczema
Pruritic urticarial papules and plaques of pregnancy
Cholestasis of pregnancy
Granulomatous disease
Tuberculosis
Actinomycosis
Sarcoidosis
Inflammatory breast carcinoma
Milk (or colostrum) stasis
Spontaneous (idiopathic)
Supernumerary or axillary breast tissue
unlikely. We believe that she had a dermatitis,
possibly secondary to a superficial candidal infec-
tion that developed into a cellulitis as a result of the
entry of bacteria through excoriations from her
scratching. The untreated cellulitis eventually pro-
gressed to a full-blown mastitis. To our knowl-
dege, this is the first report of a case of mastitis
associated with pregnancy that presented with an
indolent, chronic course.
Early treatment of mastitis has clearly been
shown to decrease the incidence of abscess forma-
tion. 3’5 Traditionally, puerperal mastitis has been
treated with oral antibiotics along with pumping or
continued nursing to facilitate milk drainage, z’3
Pumping cannot be done in cases of antepartum
mastitis because of the potential for initiating pre-
term labor. Prevention of abscess formation and
bacteremia is indicated in the gravid patient as these
conditions may also lead to premature labor and
delivery. These serious sequelae may be avoided
with the use of parenteral antibiotics.
The initial choice of antibiotics is empirical. A
failure of the patient to respond and culture results
can be used to modify the regimen. S. aureus, which
is often [3-1actamase positive, is the most commonly
cultured organism in studies of puerperal masti-
tis. 2’s’7 A penicillinase-resistant antibiotic such as
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nafcillin, which is acceptable for use in pregnancy
(class B) and is well tolerated, is a good choice.
Niebyl and colleaguesS reported the successful treat-
ment of mastitis with penicillin even when the or-
ganism recovered was resistant. The reason for this
unexpected response is not known. We prefer a
penicillinase-resistant antibiotic as it also provides
coverage for some of the less commonly involved
organisms such as S. epidermis, x-hemolytic strep-
tococci, groupA 13-hemolytic streptococci, and non-
hemolytic streptococci.
Rare organisms such as Salmonella bredeney
6 and
gram-negative organisms (Klebsiella pneumoniaes
and Serratia marcescens 1) have been reported to cause
antepartum mastitis. Thus, a Gram’s stain and cul-
ture of the nipple discharge prior to initiating anti-
biotic therapy are musts. In a patient whose history
makes an obscure organism more likely, as with a
human bite, consideration should be given to
broadening the coverage to include anaerobic and
gram-negative bacteria.
When an abscess has been diagnosed, surgical
drainage and debridement are necessary.
6 An ab-
scess can be difficult to ascertain amidst the exten-
sive inflammation seen with mastitis alone. This
was demonstrated by our patient in whom large
areas of induration could have been mistaken clini-
cally for an abscess. Thus, metronidazole was in-
cluded in the initial therapeutic regimen. Hot com-
presses can expedite resolution of the induration,
making more clear the diagnosis of mastitis without
abscess.
If a patient does not respond rapidly to treat-
ment, a more aggressive search for an abscess or an
underlying mass is indicated. Needle aspiration is
useful in diagnosing granulomatous mastitis
9 and
in obtaining material for culture in a patient whose
nipple discharge is scant or lacking. Tissue for
histology should also be obtained in refractory cases
to exclude inflammatory carcinoma.
The recognition that mastitis can occur antena-
tally and a targeted investigation to elicit predispos-
ing factors are the keys to diagnosis. The manage-
ment must be early and aggressive to prevent
complications. Our report illustrates that such an
approach can result in successful treatment with
minimal maternal or fetal morbidity.
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